Companies: 10,795·Total market cap: $144.5T
Kronos Bio, Inc.

Kronos Bio, Inc.

KRONNASDAQHealthcare
$0.88
+$0.01(+1.49%)
Market Cap$53652896
P/E Ratio—
52W High$1.46
52W Low$0.65
SEC Filings

Kronos Bio, Inc. (KRON) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001741830 · KRON · NASDAQ · as of Jun 10, 2026

Filing snapshot

308
Total Filings
15-12G
Latest Form
2025-06-30
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001741830 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-04-25
Fiscal Year End
Apr 25, 2025
Accession No.
0001741830-25-000018
Primary Document
kron-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001741830 · Accession 0001741830-25-000018

Latest Key Filings

10-QQuarterly Report
10-Q
2025-05-08
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2025-06-20Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2025-06-30
View
EFFECTEFFECT
EFFECT
2025-06-23
View
S-8 POSS-8 POS
S-8 POS
2025-06-20
View
S-8 POSS-8 POS
S-8 POS
2025-06-20
View
S-8 POSS-8 POS
S-8 POS
2025-06-20
View
S-8 POSS-8 POS
S-8 POS
2025-06-20
View
S-8 POSS-8 POS
S-8 POS
2025-06-20
View
POS AMPOS AM
POS AM
2025-06-20
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-06-20
View
25-NSE25-NSE
25-NSE
2025-06-20
View
SC 14D9/ASC 14D9/A
SOLICITATION/RECOMMENDATION STATEMENT
2025-06-20
View
8-KCurrent Report
CURRENT REPORT
2025-06-20
View
SC TO-T/ASC TO-T/A
SC TO T/A
2025-06-20
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2025-06-05
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2025-06-05
View
Showing 1–15 of 190 filingsForm 4 / 144 hidden· 308 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001741830  |  Exchange: NASDAQ · Healthcare

Kronos Bio, Inc. (NASDAQ: KRON) has submitted 308 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001741830, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Kronos Bio, Inc.'s most comprehensive regulatory disclosure. The most recent Kronos Bio, Inc. 10-K was filed on 2025-04-25 for fiscal year ending 2025. Historical KRON 10-K annual reports are available from 2018 through 2025.

Investors researching Kronos Bio, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
SYRE SEC Filings →RPHM SEC Filings →ACHL SEC Filings →TCRR SEC Filings →SGTX SEC Filings →ARPO SEC Filings →ALVR SEC Filings →BLUE SEC Filings →
→ KRON Financials→ KRON Earnings→ KRON Insider Trades

Frequently Asked Questions

KRON SEC Filings · 8 questions

Kronos Bio, Inc. (KRON) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 308 filings and access original documents at no cost. Kronos Bio, Inc.'s CIK is 0001741830.

KRON SEC filingsKronos Bio, Inc. SEC documentsfind KRON 10-K